SMYD2A Antikörper (AA 1-270)
-
- Target Alle SMYD2A Antikörper anzeigen
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
-
Bindungsspezifität
- AA 1-270
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SMYD2A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (IF)
- Sequenz
- MRAEGLGGLE RFCSPGKGRG LRALQPFQVG DLLFSCPAYA YVLTVNERGN HCEYCFTRKE GLSKCGRCKQ AFYCNVECQK EDWPMHKLEC SPMVVFGENW NPSETVRLTA RILAKQKIHP ERTPSEKLLA VKEFESHLDK LDNEKKDLIQ SDIAALHHFY SKHLGFPDND SLVVLFAQVN CNGFTIEDEE LSHLGSAIFP DVALMNHSCC PNVIVTYKGT LAEVRAVQEI KPGEEVFTSY IDLLYPTEDR NDRLRDSYFF TCECQECTTK
- Kreuzreaktivität
- Human, Maus
- Produktmerkmale
- Polyclonal Antibodies
- Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-270 of human SMYD2 (NP_064582.2).
- Isotyp
- IgG
- Top Product
- Discover our top product SMYD2A Primärantikörper
-
-
- Applikationshinweise
- WB,1:500 - 1:2000,IF,1:10 - 1:100
- Kommentare
-
HIGH QUALITY
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling." in: The Journal of biological chemistry, Vol. 292, Issue 30, pp. 12702-12712, (2017) (PubMed).
: "
-
The lysine methyltransferase SMYD2 methylates the kinase domain of type II receptor BMPR2 and stimulates bone morphogenetic protein signaling." in: The Journal of biological chemistry, Vol. 292, Issue 30, pp. 12702-12712, (2017) (PubMed).
-
- Target
- SMYD2A (SET and MYND Domain Containing 2a (SMYD2A))
- Andere Bezeichnung
- SMYD2 (SMYD2A Produkte)
- Synonyme
- HSKM-B antikoerper, KMT3C antikoerper, ZMYND14 antikoerper, 1110020E07Rik antikoerper, 4930402C15 antikoerper, Zmynd14 antikoerper, smyd2-a antikoerper, im:7146196 antikoerper, smyd2 antikoerper, wu:fc02f02 antikoerper, zgc:110553 antikoerper, si:dkey-121j17.3 antikoerper, zgc:136609 antikoerper, SET and MYND domain containing 2 antikoerper, SET and MYND domain containing 2 S homeolog antikoerper, SET and MYND domain containing 2a antikoerper, SET and MYND domain containing 2b antikoerper, SMYD2 antikoerper, Smyd2 antikoerper, smyd2.S antikoerper, smyd2a antikoerper, smyd2b antikoerper
- Hintergrund
- SET domain-containing proteins, such as SMYD2, catalyze lysine methylation (Brown et al., 2006 [PubMed 16805913]).[supplied by OMIM, Nov 2008],SMYD2,HSKM-B,KMT3C,ZMYND14,Epigenetics & Nuclear Signaling,Chromatin Modifying Enzymes,Methylation,SMYD2
- Molekulargewicht
- 30 kDa/49 kDa
- Gen-ID
- 56950
- UniProt
- Q9NRG4
-